| dc.creator |
Talha Dumlu |
|
| dc.creator |
Fatih Canan |
|
| dc.creator |
Gökhan Celbek |
|
| dc.creator |
Adem Güngör |
|
| dc.creator |
Yusuf Aydın |
|
| dc.date |
2011 |
|
| dc.date.accessioned |
2013-05-30T14:10:43Z |
|
| dc.date.available |
2013-05-30T14:10:43Z |
|
| dc.date.issued |
2013-05-30 |
|
| dc.identifier |
http://www.turknoropsikiyatri.org/default.aspx?pfn=dergiOkur&iid=51&modulePage=article&dt=eft&aid=325 |
|
| dc.identifier |
http://www.doaj.org/doaj?func=openurl&genre=article&issn=13000667&date=2011&volume=48&issue=2&spage=162 |
|
| dc.identifier.uri |
http://koha.mediu.edu.my:8181/jspui/handle/123456789/6058 |
|
| dc.description |
Mirtazapine is a noradrenergic and specific serotonergic antidepressant that is approved for use in the treatment of major depression. It is generally well tolerated with some mild side effects such as drowsiness, excessive sedation, increased appetite, weight gain, and dry mouth. We present a case of 23 years old female depressive patient who developed abdominal pain and elevation of liver enzymes during treatment with mirtazapine and returned to normal after stopping the mirtazapine use. (Archives of Neuropsychiatry 2011; 48: 162-3) |
|
| dc.publisher |
Galenos Yayicilik |
|
| dc.source |
Nöropsikiyatri Arşivi |
|
| dc.subject |
Hepatotoxicity |
|
| dc.subject |
major depression |
|
| dc.subject |
mirtazapine |
|
| dc.title |
Reversible Hepatotoxicity of Mirtazapine in a Patient with Major Depression Case Report |
|